Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRSK1 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
mRNA | ZNF551 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | ZSCAN23 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |
mRNA | ZNF184 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |
mRNA | GPR155 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | CIC | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | PHF21B | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-07 |
mRNA | SATL1 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
mRNA | ZNF549 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
mRNA | CCT3 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |